| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.5M | — | -56.1% |
| Cost of Revenue | $12.5M | — | -42.8% |
| R&D Expense | $87.9M | — | -32.2% |
| SG&A Expense | $34.6M | — | -36.7% |
| Operating Income | -$128.5M | — | +32.8% |
| Pre-tax Income | -$122.1M | — | +39.7% |
| Income Tax | -$4.6M | — | -2813.9% |
| Net Income | -$117.5M | — | +42.0% |
| EPS (Basic) | -$0.22 | — | +56.0% |
| EPS (Diluted) | -$0.22 | — | +56.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $654.5M | -11.9% | +30.8% |
| Current Assets | $709.6M | -12.7% | +21.5% |
| Total Assets | $1.34B | -9.1% | +2.6% |
| Current Liabilities | $129.7M | -12.2% | -8.7% |
| Long-term Debt | $7.2M | -24.9% | -56.3% |
| Total Liabilities | $314.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$81.1M | — | +38.5% |
| Capital Expenditures | $258K | — | -85.9% |
| Investing Cash Flow | -$338K | — | +95.4% |
| Financing Cash Flow | -$3.5M | — | -108.6% |
| Free Cash Flow | -$81.4M | — | +39.2% |
| -15.2% |
| Stockholders' Equity | $1.02B | -9.4% | +9.7% |